Business Description
Furen Group Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000NM4
Share Class Description:
SHSE:600781: Class ACompare
Compare
Traded in other countries / regions
600781.China IPO Date
1996-12-18Description
Furen Group Pharmaceutical Co Ltd, formerly Furen Pharmaceutical Group Industry Co Ltd is a pharmaceutical company. The company is engaged in the research and development, manufacturing and marketing of powder injection, lyophilized powder injection, tablets/capsules, pills, and liquid injection.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.34 | |||||
| 9-Day RSI | 45.66 | |||||
| 14-Day RSI | 45.84 | |||||
| 6-1 Month Momentum % | -62.33 | |||||
| 12-1 Month Momentum % | -56.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 11.2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.68 | |||||
| EV-to-EBITDA | -1.68 | |||||
| EV-to-Revenue | 2.22 | |||||
| Earnings Yield (Greenblatt) % | -59.52 | |||||
| FCF Yield % | 36.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Furen Group Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,581.821 | ||
| EPS (TTM) (Â¥) | -4.4 | ||
| Beta | 0 | ||
| Volatility % | 89.05 | ||
| 14-Day RSI | 45.84 | ||
| 14-Day ATR (Â¥) | 0.071881 | ||
| 20-Day SMA (Â¥) | 0.74 | ||
| 12-1 Month Momentum % | -56.48 | ||
| 52-Week Range (Â¥) | 0.51 - 3.65 | ||
| Shares Outstanding (Mil) | 627.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Furen Group Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Furen Group Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Furen Group Pharmaceutical Co Ltd Frequently Asked Questions
What is Furen Group Pharmaceutical Co Ltd(SHSE:600781)'s stock price today?
The current price of SHSE:600781 is ¥0.77. The 52 week high of SHSE:600781 is ¥3.65 and 52 week low is ¥0.51.
When is next earnings date of Furen Group Pharmaceutical Co Ltd(SHSE:600781)?
The next earnings date of Furen Group Pharmaceutical Co Ltd(SHSE:600781) is .
Does Furen Group Pharmaceutical Co Ltd(SHSE:600781) pay dividends? If so, how much?
Furen Group Pharmaceutical Co Ltd(SHSE:600781) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers